← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity

UHS logoUniversal Health Services, Inc.(UHS)Earnings, Financials & Key Ratios

UHS•NYSE
$168.49
$10.55B mkt cap·7.3× P/E·Price updated May 6, 2026
SectorHealthcareIndustryHealthcare FacilitiesSub-IndustryHospitals and inpatient facilities
AboutUniversal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. The company operates through Acute Care Hospital Services and Behavioral Health Care Services segments. Its hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services. As of February 24, 2022, it owned and/or operated 363 inpatient facilities, and 40 outpatient and other facilities located in 39 states; Washington, D.C.; the United Kingdom; and Puerto Rico. The company also provides commercial health insurance services; and various management services, which include central purchasing, information, finance and control systems, facilities planning, physician recruitment, administrative personnel management, marketing, and public relations services. Universal Health Services, Inc. founded in 1978 and is headquartered in King of Prussia, Pennsylvania.Show more
  • Revenue$17.36B+9.7%
  • EBITDA$2.61B+15.3%
  • Net Income$1.49B+30.4%
  • EPS (Diluted)23.10+37.3%
  • Gross Margin90.45%+0.5%
  • EBITDA Margin15.05%+5.1%
  • Operating Margin11.48%+8.1%
  • Net Margin8.57%+18.8%
  • ROE21.01%+19.3%
  • ROIC12.27%+12.1%
  • Debt/Equity0.74+1.4%
  • Interest Coverage13.51+50.8%
Analysis→Technical→

UHS Key Insights

Universal Health Services, Inc. (UHS) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓High quality earnings: Operating CF exceeds net income
  • ✓Good 3Y average ROE of 16.8%
  • ✓Share count reduced 5.1% through buybacks
  • ✓Trading at only 1.5x book value
  • ✓Efficient asset utilization: 1.1x turnover

✗Weaknesses

  • ✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

UHS Price & Volume

Universal Health Services, Inc. (UHS) stock price & volume — 10-year historical chart

Loading chart...

UHS Growth Metrics

Universal Health Services, Inc. (UHS) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years6.74%
5 Years8.48%
3 Years9.03%
TTM10.42%

Profit CAGR

10 Years8.14%
5 Years9.54%
3 Years30.13%
TTM27.06%

EPS CAGR

10 Years13.07%
5 Years16.02%
3 Years36.21%
TTM33.73%

Return on Capital

10 Years12.76%
5 Years12.21%
3 Years13.28%
Last Year15.97%

UHS Recent Earnings

Universal Health Services, Inc. (UHS) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 11/12 qtrs (92%)●Beat Revenue 7/12 qtrs (58%)
Q2 2026Latest
Apr 27, 2026
EPS
$5.62
Est $5.41
+3.9%
Revenue
$4.5B
Est $4.4B
+2.5%
Q1 2026
Feb 25, 2026
EPS
$5.88
Est $5.92
-0.7%
Revenue
$4.5B
Est $4.5B
-0.4%
Q4 2025
Oct 27, 2025
EPS
$5.69
Est $4.66
+22.1%
Revenue
$4.5B
Est $4.5B
-0.2%
Q3 2025
Jul 28, 2025
EPS
$5.35
Est $4.92
+8.7%
Revenue
$4.3B
Est $4.2B
+1.1%
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestApr 27, 2026
$5.62vs $5.41+3.9%
$4.5Bvs $4.4B+2.5%
Q1 2026Feb 25, 2026
$5.88vs $5.92-0.7%
$4.5Bvs $4.5B-0.4%
Q4 2025Oct 27, 2025
$5.69vs $4.66+22.1%
$4.5Bvs $4.5B-0.2%
Q3 2025Jul 28, 2025
$5.35vs $4.92+8.7%
$4.3Bvs $4.2B+1.1%
Based on last 12 quarters of dataView full earnings history →

UHS Peer Comparison

Universal Health Services, Inc. (UHS) competitors in Hospitals and inpatient facilities — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
HCA logoHCAHCA Healthcare, Inc.Direct Competitor96.01B429.4515.137.08%8.97%
THC logoTHCTenet Healthcare CorporationDirect Competitor17.04B194.5112.563.12%7.94%19.56%1.47
CYH logoCYHCommunity Health Systems, Inc.Direct Competitor404.47M2.870.76-1.18%-0.41%
ENSG logoENSGThe Ensign Group, Inc.Direct Competitor10.28B175.9330.1318.72%6.89%16.61%1.86
ACHC logoACHCAcadia Healthcare Company, Inc.Product Competitor2.33B25.30-2.085.04%-32.84%-40.92%1.24
SEM logoSEMSelect Medical Holdings CorporationProduct Competitor2.04B16.4313.925.12%2.42%6.57%1.82
SGRY logoSGRYSurgery Partners, Inc.Product Competitor1.89B14.59-23.926.24%-2.28%-2.39%1.14
USPH logoUSPHU.S. Physical Therapy, Inc.Product Competitor1.12B73.6151.8416.33%1.52%1.36%0.55

Compare UHS vs Peers

Universal Health Services, Inc. (UHS) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs HCA

Most directly comparable listed peer for UHS.

Scale Benchmark

vs UNH

Larger-name benchmark to compare UHS against a more recognizable public peer.

Peer Set

Compare Top 5

vs HCA, THC, CYH, ENSG

UHS Income Statement

Universal Health Services, Inc. (UHS) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Sales/Revenue10.41B10.77B11.38B11.56B12.64B13.4B14.28B15.83B17.36B17.76B
Revenue Growth %6.59%3.48%5.63%1.59%9.37%5.99%6.59%10.82%9.71%10.42%
Cost of Goods Sold1.11B1.17B1.25B1.29B1.43B1.47B1.53B1.59B1.66B1.26B
COGS % of Revenue10.62%10.85%11%11.14%11.29%11%10.73%10.03%9.55%-
Gross Profit
9.3B▲ 0%
9.6B▲ 3.2%
10.13B▲ 5.4%
10.27B▲ 1.4%
11.21B▲ 9.2%
11.93B▲ 6.3%
12.75B▲ 6.9%
14.24B▲ 11.7%
15.71B▲ 10.3%
12.01B▲ 0%
Gross Margin %89.38%89.15%89%88.86%88.71%89%89.27%89.97%90.45%67.62%
Gross Profit Growth %6.52%3.21%5.45%1.42%9.19%6.33%6.91%11.69%10.29%-
Operating Expenses8.02B8.43B8.91B8.91B9.85B10.92B11.57B12.56B13.71B10.47B
OpEx % of Revenue77.09%78.24%78.32%77.1%77.93%81.51%81.04%79.34%78.96%-
Selling, General & Admin5.08B5.36B5.7B5.73B6.28B6.89B7.25B7.67B8.23B6.24B
SG&A % of Revenue48.84%49.76%50.07%49.56%49.7%51.45%50.75%48.43%47.41%-
Research & Development0000000000
R&D % of Revenue----------
Other Operating Expenses2.94B3.07B3.21B3.18B3.57B4.03B4.33B4.89B5.48B3M
Operating Income
1.28B▲ 0%
1.18B▼ 8.2%
1.22B▲ 3.5%
1.36B▲ 11.7%
1.36B▲ 0.3%
1B▼ 26.4%
1.18B▲ 17.1%
1.68B▲ 43.1%
1.99B▲ 18.6%
2.04B▲ 0%
Operating Margin %12.3%10.91%10.69%11.75%10.78%7.49%8.23%10.63%11.48%11.5%
Operating Income Growth %-0.1%-8.2%3.46%11.72%0.35%-26.38%17.12%43.09%18.56%-
EBITDA1.73B1.63B1.71B1.87B1.9B1.59B1.74B2.27B2.61B2.67B
EBITDA Margin %16.6%15.12%15%16.17%15%11.83%12.21%14.32%15.05%15.02%
EBITDA Growth %1.76%-5.77%4.79%9.53%1.47%-16.39%9.97%30.01%15.27%14.01%
D&A (Non-Cash Add-back)447.76M453.05M490.39M510.49M533.21M581.86M568.04M584.83M618.74M625.82M
EBIT1.27B1.18B1.23B1.36B1.38B993.15M1.15B1.68B2.12B1.66B
Net Interest Income-142.77M-154.96M-162.73M-106.28M-83.67M-126.89M-206.67M-186.11M-156.07M-114.76M
Interest Income81K002.8M1.6M378K572K1.43M1.19M596K
Interest Expense142.85M154.96M162.73M109.09M85.27M127.27M207.25M187.53M157.26M152.49M
Other Income/Expense-145.17M-140.74M-149.57M-106.27M-69.78M-137.29M-234.96M-183.88M-21.87M-21.22M
Pretax Income
1.14B▲ 0%
1.03B▼ 8.9%
1.07B▲ 3.1%
1.25B▲ 17.4%
1.29B▲ 3.3%
866.26M▼ 33.0%
940.43M▲ 8.6%
1.5B▲ 59.3%
1.97B▲ 31.7%
2.02B▲ 0%
Pretax Margin %10.9%9.6%9.37%10.83%10.23%6.46%6.58%9.46%11.36%11.38%
Income Tax363.7M236.64M238.79M299.29M305.68M209.28M221.12M334.83M460.96M472.6M
Effective Tax Rate %32.04%22.87%22.39%23.9%23.64%24.16%23.51%22.35%23.37%23.39%
Net Income
752.3M▲ 0%
779.71M▲ 3.6%
814.85M▲ 4.5%
943.95M▲ 15.8%
991.59M▲ 5.0%
675.61M▼ 31.9%
717.79M▲ 6.2%
1.14B▲ 59.1%
1.49B▲ 30.4%
1.52B▲ 0%
Net Margin %7.23%7.24%7.16%8.17%7.84%5.04%5.03%7.22%8.57%8.56%
Net Income Growth %7.1%3.64%4.51%15.84%5.05%-31.87%6.24%59.11%30.36%27.06%
Net Income (Continuing)771.31M797.88M827.54M952.79M987.63M656.98M719.31M1.16B1.51B1.54B
Discontinued Operations0000000000
Minority Interest68.62M80.82M79.1M89.39M108.51M49.46M52.91M96.61M133.62M73.38M
EPS (Diluted)
7.81▲ 0%
8.32▲ 6.5%
9.13▲ 9.7%
10.99▲ 20.4%
11.82▲ 7.6%
9.14▼ 22.7%
10.23▲ 11.9%
16.82▲ 64.4%
23.10▲ 37.3%
-▲ 0%
EPS Growth %9.38%6.53%9.74%20.37%7.55%-22.67%11.93%64.42%37.34%33.73%
EPS (Basic)7.868.369.1611.0611.999.2310.3517.1623.42-
Diluted Shares Outstanding96.33M93.75M89.04M85.59M83.69M73.83M70.13M67.9M64.46M0
Basic Shares Outstanding95.65M93.28M88.76M85.06M82.52M73.12M69.32M66.55M63.58M0
Dividend Payout Ratio5.08%4.79%6.5%1.84%6.65%8.65%7.73%4.67%3.44%-

UHS Balance Sheet

Universal Health Services, Inc. (UHS) balance sheet — assets, liabilities & shareholders' equity

Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Current Assets1.8B1.94B1.92B3.28B2.26B2.54B2.81B2.82B3.41B3.5B
Cash & Short-Term Investments74.42M105.22M61.27M1.22B115.3M102.82M119.44M125.98M137.8M119.03M
Cash Only74.42M105.22M61.27M1.22B115.3M102.82M119.44M125.98M137.8M119.03M
Short-Term Investments0000000000
Accounts Receivable1.5B1.51B1.56B1.73B1.75B2.02B2.24B2.18B2.6B2.75B
Days Sales Outstanding52.6351.1650.0754.650.4354.9657.250.2254.752.59
Inventory136.18M148.21M159.89M190.42M206.84M218.52M216.99M220.94M232.11M0
Days Inventory Outstanding44.9846.2946.6453.9652.954.151.6750.7951.0749.51
Other Current Assets86.5M174.47M133.93M138.03M194.78M198.28M236.66M291.61M381.57M635.58M
Total Non-Current Assets8.96B9.33B9.75B10.2B10.83B10.96B11.16B11.65B12.55B12.18B
Property, Plant & Equipment4.57B4.85B5.34B5.71B6.24B6.37B6.56B6.99B7.38B13.99B
Fixed Asset Turnover2.28x2.22x2.13x2.02x2.03x2.10x2.18x2.26x2.35x1.97x
Goodwill3.83B3.84B3.87B3.88B3.96B3.91B3.93B3.93B3.99B3.98B
Intangible Assets000000076.27M75.88M0
Long-Term Investments0000000318.73M346.23M680.47M
Other Non-Current Assets563.83M629.83M523.15M579.97M579.9M605.89M579.73M216.19M254.5M-4.74B
Total Assets
10.76B▲ 0%
11.27B▲ 4.7%
11.67B▲ 3.6%
13.48B▲ 15.5%
13.09B▼ 2.8%
13.49B▲ 3.1%
13.97B▲ 3.5%
14.47B▲ 3.6%
15.96B▲ 10.3%
15.68B▲ 0%
Asset Turnover0.97x0.96x0.98x0.86x0.97x0.99x1.02x1.09x1.09x1.15x
Asset Growth %4.3%4.68%3.58%15.5%-2.84%3.06%3.51%3.6%10.28%29.09%
Total Current Liabilities1.85B1.45B1.56B2.48B1.98B1.91B2.01B2.21B3.24B3.24B
Accounts Payable441.98M445.65M446.96M570.52M658.9M636.6M613.97M632M750.13M0
Days Payables Outstanding145.98139.19130.37161.66168.52157.6146.2145.28165.04383.57
Short-Term Debt545.62M63.45M87.55M332M48.41M81.45M126.69M40.06M821.39M829.14M
Deferred Revenue (Current)000376.15M6K2.4M5.38M000
Other Current Liabilities343.22M472.53M524.63M410.17M466.35M470.86M549.47M622.63M984.56M2.41B
Current Ratio0.97x1.34x1.23x1.32x1.14x1.33x1.40x1.27x1.05x1.05x
Quick Ratio0.90x1.24x1.12x1.25x1.04x1.21x1.29x1.17x0.98x0.98x
Cash Conversion Cycle-48.38-41.74-33.66-53.11-65.19-48.54-37.33-44.27-59.27-281.48
Total Non-Current Liabilities3.86B4.35B4.52B4.59B4.91B5.61B5.75B5.5B5.31B4.91B
Long-Term Debt3.49B3.94B3.9B3.52B4.14B4.73B4.79B4.46B4.26B4.3B
Capital Lease Obligations00270.08M278.3M304.62M395.52M382.56M376.24M426.1M1.12B
Deferred Tax Liabilities54.96M49.66M25.07M5.58M0000435.14M438.38M
Other Non-Current Liabilities306.3M361.81M329.93M458.55M464.76M487.67M584.01M655.81M187.11M2.01B
Total Liabilities5.7B5.8B6.09B7.07B6.9B7.52B7.77B7.71B8.55B8.11B
Total Debt4.04B4B4.31B4.19B4.56B5.27B5.37B4.96B5.51B5.13B
Net Debt3.97B3.89B4.25B2.97B4.44B5.17B5.25B4.83B5.37B5.01B
Debt / Equity0.80x0.73x0.77x0.65x0.74x0.88x0.87x0.73x0.74x0.74x
Debt / EBITDA2.34x2.46x2.53x2.24x2.40x3.32x3.08x2.19x2.11x1.92x
Net Debt / EBITDA2.29x2.39x2.49x1.59x2.34x3.26x3.01x2.13x2.06x2.06x
Interest Coverage8.88x7.63x7.55x12.45x16.15x7.80x5.53x8.96x13.51x10.92x
Total Equity
5.06B▲ 0%
5.47B▲ 8.1%
5.58B▲ 2.1%
6.41B▲ 14.7%
6.2B▼ 3.3%
5.97B▼ 3.7%
6.2B▲ 3.9%
6.76B▲ 9.0%
7.41B▲ 9.6%
7.6B▲ 0%
Equity Growth %9.79%8.14%2.07%14.75%-3.25%-3.68%3.88%9.04%9.56%38.12%
Book Value per Share52.5158.3562.7074.8574.0680.8688.4499.61114.94114.94
Total Shareholders' Equity4.99B5.39B5.5B6.32B6.09B5.92B6.15B6.67B7.28B7.53B
Common Stock942K914K867K851K771K710K672K650K611K7.46B
Retained Earnings4.98B5.38B5.47B6.27B6.06B5.93B6.8B7.37B7.99B0
Treasury Stock0000000000
Accumulated OCI7.18M4.24M31.89M48.12M30.29M-9.67M-650.6M-706.5M-717.57M0
Minority Interest68.62M80.82M79.1M89.39M108.51M49.46M52.91M96.61M133.62M73.38M

UHS Cash Flow Statement

Universal Health Services, Inc. (UHS) cash flow — operating, investing & free cash flow history

Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations1.18B1.34B1.44B2.36B883.7M996.02M1.27B2.07B1.86B1.86B
Operating CF Margin %11.36%12.45%12.64%20.42%6.99%7.43%8.88%13.06%10.74%-
Operating CF Growth %-8.22%13.39%7.28%64.08%-62.56%12.71%27.29%63.05%-9.81%-6.03%
Net Income771.31M797.88M827.54M952.79M987.63M656.98M717.49M1.16B1.51B1.52B
Depreciation & Amortization447.88M453.08M490.39M510.49M533.21M581.86M568.04M584.83M618.74M625.82M
Stock-Based Compensation56.74M66.58M69.43M65.84M73.69M85.38M87.72M99.35M95.69M72.48M
Deferred Taxes049.52M90.09M3.32M26.05M00000
Other Non-Cash Items-79.19M-76.15M-97.78M-109.76M0-83.85M-124.34M-198.95M-85.32M-314.13M
Working Capital Changes-14.16M49.98M58.79M940.81M-736.89M-244.35M17.07M418.76M-275.89M-2.1M
Change in Receivables-24.72M-42.24M-42.06M-145.9M-8.87M-258.34M-182.44M67.36M-317.99M-223.47M
Change in Inventory0000000000
Change in Payables0000000000
Cash from Investing-624.4M-813.4M-688.41M-802.56M-914.47M-647.3M-763.27M-911.11M-1.07B-996.9M
Capital Expenditures-609.43M-811.67M-663.52M-734.21M-855.66M-734M-743.05M-943.81M-1.02B-1.01B
CapEx % of Revenue5.85%7.53%5.83%6.35%6.77%5.48%5.2%5.96%5.85%-
Acquisitions-15.08M-15.23M-14.58M-54.78M-105.31M-20.31M-3.73M-18.72M-31.94M-26.24M
Investments----------
Other Investing108K13.5M-10.31M8.07M46.51M12M-16.51M51.42M28.69M44.17M
Cash from Financing-519.15M-492.2M-845.04M-384.86M-1.07B-318.4M-493.94M-1.14B-749.73M-880.2M
Debt Issued (Net)-102.01M-53.04M-17.92M-160.97M217.11M615.95M99.62M-429.75M241.65M98.69M
Equity Issued (Net)-364.4M-397.43M-770.5M-206.72M-1.22B-832.92M-547.36M-655.68M-951.22M-731.5M
Dividends Paid-38.21M-37.34M-53M-17.34M-65.9M-58.45M-55.48M-53.35M-51.27M-50.71M
Share Repurchases-364.4M-397.43M-770.5M-206.72M-1.22B-832.92M-547.36M-670.75M-967.95M-908.41M
Other Financing-14.54M-4.4M-3.61M172K715K-42.99M9.28M-6.09M11.11M-196.69M
Net Change in Cash
40.68M▲ 0%
32.39M▼ 20.4%
-94.02M▼ 390.3%
1.17B▲ 1348.2%
-1.1B▼ 193.8%
21.9M▲ 102.0%
13.63M▼ 37.8%
10.28M▼ 24.6%
46.57M▲ 352.9%
-990K▲ 0%
Free Cash Flow
573.15M▲ 0%
529.22M▼ 7.7%
774.95M▲ 46.4%
1.63B▲ 109.8%
28.04M▼ 98.3%
262.02M▲ 834.6%
524.74M▲ 100.3%
1.12B▲ 114.1%
849.25M▼ 24.4%
894.02M▲ 0%
FCF Margin %5.51%4.91%6.81%14.07%0.22%1.96%3.67%7.1%4.89%5.03%
FCF Growth %330.11%-7.66%46.43%109.81%-98.28%834.59%100.27%114.07%-24.4%-15.37%
FCF per Share5.955.658.7019.000.333.557.4816.5413.1713.17
FCF Conversion (FCF/Net Income)1.57x1.72x1.77x2.50x0.89x1.47x1.77x1.81x1.25x0.59x
Interest Paid135.53M150.29M157.41M112.6M75.61M120.14M200.45M168.27M075.33M
Taxes Paid370.86M293.84M260.62M286.25M362.98M250.76M257.9M325.43M0350.33M

UHS Key Ratios

Universal Health Services, Inc. (UHS) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201720182019202020212022202320242025TTM
Return on Equity (ROE)15.57%14.81%14.74%15.75%15.73%11.1%11.79%17.62%21.01%20.65%
Return on Invested Capital (ROIC)10.83%9.59%9.5%10.61%10.21%6.91%7.81%10.95%12.27%12.27%
Gross Margin89.38%89.15%89%88.86%88.71%89%89.27%89.97%90.45%67.62%
Net Margin7.23%7.24%7.16%8.17%7.84%5.04%5.03%7.22%8.57%8.56%
Debt / Equity0.80x0.73x0.77x0.65x0.74x0.88x0.87x0.73x0.74x0.74x
Interest Coverage8.88x7.63x7.55x12.45x16.15x7.80x5.53x8.96x13.51x10.92x
FCF Conversion1.57x1.72x1.77x2.50x0.89x1.47x1.77x1.81x1.25x0.59x
Revenue Growth6.59%3.48%5.63%1.59%9.37%5.99%6.59%10.82%9.71%10.42%

UHS SEC Filings & Documents

Universal Health Services, Inc. (UHS) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Apr 28, 2026·SEC

Material company update

Apr 24, 2026·SEC

Material company update

Mar 30, 2026·SEC

10-K Annual Reports

4
FY 2026

Feb 25, 2026·SEC

FY 2025

Feb 26, 2025·SEC

FY 2024

Feb 27, 2024·SEC

10-Q Quarterly Reports

6
FY 2025

Nov 7, 2025·SEC

FY 2025

Aug 8, 2025·SEC

FY 2025

May 8, 2025·SEC

UHS Frequently Asked Questions

Universal Health Services, Inc. (UHS) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Universal Health Services, Inc. (UHS) reported $17.76B in revenue for fiscal year 2025. This represents a 1392% increase from $1.19B in 1996.

Universal Health Services, Inc. (UHS) grew revenue by 9.7% over the past year. This is steady growth.

Yes, Universal Health Services, Inc. (UHS) is profitable, generating $1.52B in net income for fiscal year 2025 (8.6% net margin).

Dividend & Returns

Yes, Universal Health Services, Inc. (UHS) pays a dividend with a yield of 0.47%. This makes it attractive for income-focused investors.

Universal Health Services, Inc. (UHS) has a return on equity (ROE) of 21.0%. This is excellent, indicating efficient use of shareholder capital.

Universal Health Services, Inc. (UHS) generated $894.0M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More UHS

Universal Health Services, Inc. (UHS) financial analysis — history, returns, DCA and operating performance tools

Full UHS Stock Analysis

Analyst verdict, bull/bear case, risk factors and peer comparison

→

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.